Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and therapy, 2016 - Taylor & Francis
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
[HTML][HTML] Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and therapy, 2016 - ncbi.nlm.nih.gov
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and therapy, 2016 - pubmed.ncbi.nlm.nih.gov
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and Therapy, 2016 - search.proquest.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond.
Z Hao, I Sadek - Oncotargets and Therapy, 2016 - europepmc.org
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
[PDF][PDF] Sunitinib: the antiangiogenic effects and beyond
Z Hao - OncoTargets and Therapy, 2016 - scienceopen.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and Therapy, 2016 - go.gale.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: The antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and Therapy, 2016 - augusta.elsevierpure.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond.
Z Hao, I Sadek - OncoTargets & Therapy, 2016 - search.ebscohost.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
Sunitinib: the antiangiogenic effects and beyond
Z Hao, I Sadek - OncoTargets and Therapy, 2016 - dovepress.com
As a multitargeted kinase inhibitor, sunitinib has carved its way into demonstrating itself as a
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …
most effective tyrosine kinase inhibitor in the treatment of metastatic renal cell carcinoma …